Abstract:
A substantially flat collapsed plastic bag with an evacuation form unit insert positioned therein as manufactured to serve as a form about which the filled bag will collapse as it is emptied. The form unit comprises a ring for mounting the unit on the spout of the bag and a multi-channel form extending radially from the ring and hingedly connected thereto. A simple method is provided for manufacturing the bag with the form unit insert.
Abstract:
Carbapenem compounds of formula (I): ##STR1## [in which: A is a fully saturated heterocyclic group, of which at least one ring atom is nitrogen; R.sup.1 is hydrogen or methyl; R.sup.2 is hydrogen or alkyl; R.sup.3 is hydrogen or a negative ion; Q is: (i) --B--N.sup.+ R.sup.8 R.sup.9 R.sup.10, where R.sup.8, R.sup.9 and R.sup.10 are alkenyl, alkynyl or optionally substituted alkyl, and B is alkylene or alkylidene; (ii) a heterocyclic group of which one ring atom is a >N.sup.+ R.sup.11 R.sup.12, where R.sup.11 and R.sup.12 are alkenyl, alkynyl or optionally substituted alkyl; (iii) alkyl substituted by a heterocyclic group as defined in (ii) above; or (iv) alkyl substituted by an aromatic heterocyclic group, of which one ring atom is ##STR2## or R.sup.2 and Q, and the nitrogen to which they are attached, form a group of formula (II): ##STR3## where m and n are 1, 2 or 3; R.sup.6 is optionally substituted alkyl; and R.sup.7 is alkenyl, alkynyl or optionally substituted alkyl] and pharmaceutically acceptable salts and esters thereof have valuable antibacterial activity with enhanced resistance to dehydropeptidase I and .beta.-lactamase. Methods of preparing and using the compounds are also provided.
Abstract:
6-(1'-fluorethyl)- and 6-(1'-fluoro-1'-methylethyl)-carbapenems such as (5RS,6RS)-1-aza-6-(1(RS)-fluorethyl)-3-(N'-dimethyl-N'-methylamidinomethylthio)-7-oxobicyclo[3.2.0]hept-2-ene-2-carboxylic acid which are useful as chemotherapeutic agents in particular as anti-bacterially active anti-biotics.
Abstract:
Antibacterial carbapenem compounds represented by the general formula ##STR1## wherein X is hydrogen or alkyl, A is hydrogen or alkyl, R is hydrogen or a monovalent substituent and COB is carboxy, its pharmaceutically acceptable ester or its alkali metal salt are prepared from the suitably substituted monocyclic 2-azetidinone by a Wittig cyclization or carbene-insertion cyclization to give Compounds(I) or by cleaving the dioxolane ring of above Compounds(I) with a strong base e.g. DEN or DBU to give above Compounds(II). Some other alterations of COB, R and side chain structure are also disclosed.
Abstract:
Diclosed is a process for preparing the antibiotic 6-hydroxymethyl-2-(.beta.-aminoethylthio)-1-carbadethiapen-2-em-3-carboxylic acid (I) ##STR1## and its pharmaceutically acceptable salt and ester derivatives.
Abstract:
Antimicrobial quinolnyl lactam esters comprising a lactam-containing moiety linked, by an ester group, to the 3-carboxy group of a quinolone moiety. These compounds are of the formula: ##STR1## wherein (1) R.sup.3, R.sup.4, and R.sup.5, together with bonds "a" and "b", form certain lactam-containing moieties similar to those known in the art to have antimicrobial activity; and(2) A, R.sup.6, R.sup.7, and R.sup.8 form any of a variety of quinolone or napthyridine structures similar to those known in the art to have antimicrobial activity.
Abstract:
In a process for the total synthesis of thienamycin from L-aspartic acid via intermediate III: ##STR1## R=H, blocking group or salt cation there is disclosed a process for preparing III via ##STR2## wherein R is a protecting group.
Abstract:
A compound represented by the following formula: ##STR1## wherein R.sub.1 represents a hydrogen atom or a hydroxyl group, R.sub.2 represents a group of the formula --CH.sub.2 NO.sub.2, --CN.fwdarw.O or ##STR2## in which A represents a group of the formula ##STR3## in which R.sub.4 represents a hydrogen atom or an alkoxycarbonyl group, R.sub.5 represents a phenyl, alkoxycarbonyl or alkanoyloxymethyl group, R.sub.6 represents an alkyl group and R.sub.7 represents a phenyl, naphthyl, pyridyl, furyl or thienyl group; and R.sub.3 represents a hydrogen atom or a substituted or unsubstituted hydrocarbon group, and a process for production thereof.
Abstract translation:由下式表示的化合物:其中R1表示氢原子或羟基,R2表示式-CH2NO2,-CN-> O或其中A表示式 其中R 4表示氢原子或烷氧基羰基,R 5表示苯基,烷氧基羰基或烷酰氧基甲基,R 6表示烷基,R 7表示苯基,萘基,吡啶基,呋喃基或噻吩基。 R 3表示氢原子或取代或未取代的烃基,及其制造方法。
Abstract:
Disclosed is a process for the total synthesis of 1-carbapenem antibiotics (I) from L-aspartic acid via central intermediates II and III: ##STR1## wherein R is hydrogen, a pharmaceutically acceptable ester moiety or salt cation, or a readily removable blocking group; R.sup.6, R.sup.7 and R.sup.8 are, inter alia, independently selected from the group consisting of hydrogen, alkyl, alkenyl, aryl and aralkyl; R.sup.1' and R.sup.e are hydrogen, or a readily removable protecting group; R.sup.a, R.sup.b and R.sup.c are selected from alkyl, aryl or aralkyl.
Abstract translation:公开了通过中心中间体II和III从L-天冬氨酸全合成1-碳青霉烯类抗生素(I)的方法:其中R是氢,药学上可接受的酯部分 或盐阳离子,或易于除去的封闭基团; R6,R7和R8特别是独立地选自氢,烷基,烯基,芳基和芳烷基; R 1和Re为氢或易脱除的保护基; R a,R b和R c选自烷基,芳基或芳烷基。
Abstract:
Disclosed is 2 and a process for its preparation: ##STR1## It is useful in the synthesis of N-formimidoyl thienamycin; R.sup.2 is hydrogen or a protecting group.